Beata Stanisz

2.1k total citations · 1 hit paper
68 papers, 1.5k citations indexed

About

Beata Stanisz is a scholar working on Analytical Chemistry, Organic Chemistry and Pharmacology. According to data from OpenAlex, Beata Stanisz has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Analytical Chemistry, 15 papers in Organic Chemistry and 14 papers in Pharmacology. Recurrent topics in Beata Stanisz's work include Analytical Methods in Pharmaceuticals (30 papers), Analytical Chemistry and Chromatography (14 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Beata Stanisz is often cited by papers focused on Analytical Methods in Pharmaceuticals (30 papers), Analytical Chemistry and Chromatography (14 papers) and Antibiotics Pharmacokinetics and Efficacy (11 papers). Beata Stanisz collaborates with scholars based in Poland, Czechia and Vietnam. Beata Stanisz's co-authors include Dariusz T. Młynarczyk, Tomasz Gośliński, Joanna Musiał, Katarzyna Regulska, Łukasz Sobotta, Beata Czarczyńska-Goślińska, Arleta Glowacka-Sobotta, Daniel Ziental, Miłosz Regulski and Marek Murias and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Molecules.

In The Last Decade

Beata Stanisz

66 papers receiving 1.4k citations

Hit Papers

Titanium Dioxide Nanoparticles: Prospects and Application... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beata Stanisz Poland 15 531 306 241 232 158 68 1.5k
Slobodan Petrović Serbia 18 222 0.4× 291 1.0× 165 0.7× 179 0.8× 253 1.6× 111 1.4k
Muhammad Ali Sheraz Pakistan 21 215 0.4× 84 0.3× 189 0.8× 210 0.9× 121 0.8× 71 1.3k
Mostafa F. Al-Hakkani Egypt 20 606 1.1× 137 0.4× 244 1.0× 114 0.5× 218 1.4× 32 1.2k
A. Vijaya Bhaskar Reddy Malaysia 22 356 0.7× 163 0.5× 346 1.4× 302 1.3× 315 2.0× 52 1.7k
Ali Mohammadi Iran 32 434 0.8× 261 0.9× 497 2.1× 1.1k 4.9× 194 1.2× 144 3.0k
Yan Cui China 35 1.2k 2.3× 252 0.8× 398 1.7× 235 1.0× 154 1.0× 122 3.1k
Sayed A. Ahmed Egypt 27 528 1.0× 348 1.1× 414 1.7× 130 0.6× 896 5.7× 105 2.6k
Joanna Karpińska Poland 24 248 0.5× 273 0.9× 233 1.0× 435 1.9× 241 1.5× 91 1.9k
G. Madhavi India 25 548 1.0× 199 0.7× 442 1.8× 244 1.1× 202 1.3× 72 2.0k
Jolanta Flieger Poland 25 427 0.8× 58 0.2× 373 1.5× 296 1.3× 279 1.8× 118 2.6k

Countries citing papers authored by Beata Stanisz

Since Specialization
Citations

This map shows the geographic impact of Beata Stanisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beata Stanisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beata Stanisz more than expected).

Fields of papers citing papers by Beata Stanisz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beata Stanisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beata Stanisz. The network helps show where Beata Stanisz may publish in the future.

Co-authorship network of co-authors of Beata Stanisz

This figure shows the co-authorship network connecting the top 25 collaborators of Beata Stanisz. A scholar is included among the top collaborators of Beata Stanisz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beata Stanisz. Beata Stanisz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolenda, Tomasz, Kacper Guglas, Katarzyna Regulska, et al.. (2025). AURKAPS1, HERC2P2 and SDHAP1 pseudogenes: molecular role in development and progression of head and neck squamous cell carcinomas and their diagnostic utility. Reports of Practical Oncology & Radiotherapy. 29(6). 718–731.
2.
Stanisz, Małgorzata, Beata Stanisz, & Judyta Cielecka‐Piontek. (2024). A Comprehensive Review on Deep Eutectic Solvents: Their Current Status and Potential for Extracting Active Compounds from Adaptogenic Plants. Molecules. 29(19). 4767–4767. 12 indexed citations
3.
Regulska, Katarzyna, et al.. (2023). Impact of ramipril nitroso-metabolites on cancer incidence — in silico and in vitro safety evaluation. Reports of Practical Oncology & Radiotherapy. 28(5). 612–622. 3 indexed citations
4.
Regulska, Katarzyna, et al.. (2023). In silico and in vitro screening for carcinogenic potential of angiotensin-converting enzyme inhibitors and their degradation impurities. Toxicology and Applied Pharmacology. 469. 116541–116541. 2 indexed citations
5.
Regulska, Katarzyna, et al.. (2023). The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic. Applied Sciences. 13(4). 2358–2358. 5 indexed citations
6.
Musiał, Joanna, Dariusz T. Młynarczyk, Michał Kryjewski, et al.. (2022). Nanocomposites of Titanium Dioxide and Peripherally Substituted Phthalocyanines for the Photocatalytic Degradation of Sulfamethoxazole. Nanomaterials. 12(19). 3279–3279. 8 indexed citations
7.
Musiał, Joanna, Dariusz T. Młynarczyk, & Beata Stanisz. (2022). Photocatalytic degradation of sulfamethoxazole using TiO2-based materials – Perspectives for the development of a sustainable water treatment technology. The Science of The Total Environment. 856(Pt 2). 159122–159122. 121 indexed citations
8.
Musiał, Joanna, Robert Frankowski, Marcin Spychała, et al.. (2020). Phthalocyanine-Grafted Titania Nanoparticles for Photodegradation of Ibuprofen. Catalysts. 10(11). 1328–1328. 12 indexed citations
9.
Regulska, Katarzyna, et al.. (2019). Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing. Drug Discovery Today. 24(4). 1059–1065. 31 indexed citations
10.
Regulski, Miłosz, Katarzyna Regulska, Wiesław Prukała, et al.. (2015). COX-2 inhibitors: a novel strategy in the management of breast cancer. Drug Discovery Today. 21(4). 598–615. 87 indexed citations
11.
Regulska, Katarzyna, Beata Stanisz, Miłosz Regulski, & Marek Murias. (2014). How to design a potent, specific, and stable angiotensin-converting enzyme inhibitor. Drug Discovery Today. 19(11). 1731–1743. 28 indexed citations
12.
Regulska, Katarzyna, Marek Murias, Beata Stanisz, & Miłosz Regulski. (2014). The mutagenicity analysis of imidapril hydrochloride and its degradant, diketopiperazine derivative, nitrosation mixtures by in vitro Ames test with two strains of Salmonella typhimurium. Reports of Practical Oncology & Radiotherapy. 19(6). 412–419. 6 indexed citations
13.
Regulska, Katarzyna, et al.. (2014). Molecular fundamentals of drug interactions in the therapy of colorectal cancer. Postępy Higieny i Medycyny Doświadczalnej. 68. 209–218.
14.
Regulski, Miłosz, et al.. (2014). Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors. Current Pharmaceutical Design. 21(13). 1764–1775. 43 indexed citations
15.
Regulska, Katarzyna, Marek Murias, Beata Stanisz, & Miłosz Regulski. (2013). Is there any association between imidapril hydrochloride stability profile under dry air conditions and cancer initiation?. International Journal of Pharmaceutics. 456(2). 332–339. 7 indexed citations
16.
Regulska, Katarzyna, et al.. (2013). Optimization of Storage and Manufacture Conditions for Imidapril Hydrochloride in Solid State as a Way to Reduce Costs of Antihypertensive Therapy. AAPS PharmSciTech. 14(3). 1199–1208. 11 indexed citations
17.
Regulska, Katarzyna, Beata Stanisz, & Miłosz Regulski. (2013). The Renin-angiotensin System as a Target of Novel Anticancer Therapy. Current Pharmaceutical Design. 19(40). 7103–7125. 20 indexed citations
18.
Stanisz, Beata, et al.. (2012). Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. Drug Development and Industrial Pharmacy. 39(1). 51–61. 16 indexed citations
19.
Regulska, Katarzyna, Beata Stanisz, & Miłosz Regulski. (2012). Individualization of anticancer therapy; molecular targets of novel drugs in oncology. Postępy Higieny i Medycyny Doświadczalnej. 66. 855–867. 2 indexed citations
20.
Stanisz, Beata. (2003). Evaluation of stability of enalapril maleate in solid phase. Journal of Pharmaceutical and Biomedical Analysis. 31(2). 375–380. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026